Im Cannabis Corp (IMCC) - Total Assets
Based on the latest financial reports, Im Cannabis Corp (IMCC) holds total assets worth $31.74 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See IMCC net asset value for net asset value and shareholders' equity analysis.
Im Cannabis Corp - Total Assets Trend (2003–2025)
This chart illustrates how Im Cannabis Corp's total assets have evolved over time, based on quarterly financial data.
Im Cannabis Corp - Asset Composition Analysis
Current Asset Composition (December 2025)
Im Cannabis Corp's total assets of $31.74 Million consist of 71.7% current assets and 28.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.6% |
| Accounts Receivable | $12.98 Million | 40.9% |
| Inventory | $4.27 Million | 13.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.22 Million | 3.9% |
| Goodwill | $1.89 Million | 5.9% |
Asset Composition Trend (2003–2025)
This chart illustrates how Im Cannabis Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see IMCC company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Im Cannabis Corp's current assets represent 71.7% of total assets in 2025, a decrease from 84.6% in 2003.
- Cash Position: Cash and equivalents constituted 8.6% of total assets in 2025, down from 81.8% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2003.
- Asset Diversification: The largest asset category is accounts receivable at 40.9% of total assets.
Im Cannabis Corp Competitors by Total Assets
Key competitors of Im Cannabis Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Daihan Pharmaceutical Co.Ltd
KQ:023910
|
Korea | ₩344.02 Billion |
|
Aurobindo Pharma Limited
NSE:AUROPHARMA
|
India | Rs525.46 Billion |
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999
|
China | CN¥56.56 Billion |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538
|
China | CN¥4.75 Billion |
|
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332
|
China | CN¥7.26 Billion |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
|
China | CN¥2.26 Billion |
|
Zhejiang Cheng Yi Pharmaceutical Co Ltd
SHG:603811
|
China | CN¥1.69 Billion |
|
Hainan Honz Pharmaceutical Co
SHE:300086
|
China | CN¥1.88 Billion |
Im Cannabis Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.67 | 0.67 | 2.31 |
| Quick Ratio | 0.54 | 0.58 | 1.67 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-11.27 Million | $-11.55 Million | $30.51 Million |
Im Cannabis Corp - Advanced Valuation Insights
This section examines the relationship between Im Cannabis Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.95 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | -19.0% |
| Total Assets | $31.74 Million |
| Market Capitalization | $1.80 Million USD |
Valuation Analysis
Below Book Valuation: The market values Im Cannabis Corp's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Im Cannabis Corp's assets decreased by 19.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Im Cannabis Corp (2003–2025)
The table below shows the annual total assets of Im Cannabis Corp from 2003 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $31.74 Million | -19.02% |
| 2024-12-31 | $39.19 Million | -19.72% |
| 2023-12-31 | $48.81 Million | -19.55% |
| 2022-12-31 | $60.68 Million | -78.89% |
| 2021-12-31 | $287.39 Million | +653.98% |
| 2020-12-31 | $38.12 Million | +23.38% |
| 2019-12-31 | $30.89 Million | +83390.53% |
| 2018-12-31 | $37.00K | +304.71% |
| 2017-12-31 | $9.14K | +3212.68% |
| 2016-12-31 | $276.00 | 0.00% |
| 2015-12-31 | $276.00 | -98.29% |
| 2014-12-31 | $16.10K | -43.96% |
| 2013-12-31 | $28.73K | -68.83% |
| 2012-12-31 | $92.16K | -99.05% |
| 2011-12-31 | $9.71 Million | +2.78% |
| 2010-12-31 | $9.45 Million | +1.93% |
| 2009-12-31 | $9.27 Million | +44.61% |
| 2008-12-31 | $6.41 Million | +124.93% |
| 2007-12-31 | $2.85 Million | +70.18% |
| 2006-12-31 | $1.67 Million | +51.89% |
| 2005-12-31 | $1.10 Million | -4.01% |
| 2004-12-31 | $1.15 Million | +30.21% |
| 2003-12-31 | $881.92K | -- |
About Im Cannabis Corp
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv-Yafo, Israel.